Publikationen im NUM
Hier finden Sie eine Liste der Publikationen, die im Zusammenhang mit dem Netzwerk Universitätsmedizin in der ersten und zweiten Förderphase entstanden sind.
Föh B,
Borsche M,
Balck A,
et al .
Complications of nasal and pharyngeal swabs – a relevant challenge of the COVID-19 pandemic?.
Eur Respir J.
2021;
[DOI]
Piechotta V,
Iannizzi C,
Chai KL,
Valk SJ,
Kimber C,
Dorando E,
Monsef I,
Wood EM,
Lamikanra AA,
Roberts DJ,
McQuilten Z,
So-Osman C,
Estcourt LJ,
Skoetz N.
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review.
Cochrane Database of Systematic Reviews.
2021;
2021CD013600.
[DOI]
Beierle F,
et al .
Corona Health—A Study- and Sensor-Based Mobile App Platform Exploring Aspects of the COVID-19 Pandemic.
Int J Environ Res Public Health.
2021;
187395.
[DOI]
Steudte-Schmiedgen S,
Stieler L,
Erim Y,
Morawa E,
Geiser F,
Beschoner P,
Jerg-Bretzke L,
Albus C,
Hiebel N,
Weidner K.
Correlates and Predictors of PTSD Symptoms Among Healthcare Workers During the COVID-19 Pandemic: Results of the egePan-VOICE Study.
Frontiers in Psychiatry.
2021;
12
[DOI]
[Datei]
Ebigbo A,
Römmele C,
Bartenschlager C,
et al .
Cost-effectiveness analysis of SARS-CoV-2 infection prevention strategies including pre-endoscopic virus testing and use of high risk personal protective equipment.
Endoscopy.
2021;
53(2):
[DOI]
Baumann M.
COVID-19 and mental health in children and adolescents: a diagnostic panel to map psycho-social consequences in the pandemic context.
Discov Ment Health.
2021;
1(1):2.
[DOI]
Ritschel N,
Radbruch H,
Herden C,
Schneider N,
Dittmayer C,
Franz ea.
COVID-19 and the central and peripheral nervous system.
Pathologe.
2021;
42172—182.
[DOI]
Adhikary P,
Ul Ain Q,
Hocke A,
Hedtrich S.
COVID-19 highlights the model dilemma in biomedical research.
Nat Rev Mater.
2021;
1—3.
Roth W,
Boor P.
COVID-19 im Spiegel der Pathologie [COVID-19 in the mirror of pathology].
Pathologe.
2021;
42(2):147-148.
Gaitzsch E,
et al .
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.
HemaSphere.
2021;
5e603.
[DOI]
Gaitzsch E,
Passerini V,
Khatamzas E,
et al .
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.
Hemasphere.
2021;
5(7):
[DOI]
Heinemann S,
Bludau A,
Kaba H,
et al .
COVID-19 surveillance and testing strategies für patiens in German hospitals – results from a cross-sectional study.
DGHM.
2021;
[Datei]
Bludau A,
Anton M,
Heinemann S,
et al .
COVID-19 vaccination and immunization surveillance for employees in German hospitals – results from a cross-sectional study.
DGHM.
2021;
[Datei]
Tanacli R,
Doeblin P,
Götze C,
Zieschang V,
Faragli A,
Stehning C,
Korosoglou G,
Erley J,
Weiss J,
Berger A,
others .
COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy.
Front Cardiovasc Med.
2021;
8737257.
[DOI]
Amann K,
Boor P,
Wiech T,
Singh J,
Vonbrunn E,
Knöll A,
Hermann M,
Büttner-Herold M,
Daniel C,
Hartmann A.
COVID-19-Auswirkungen auf die Niere [COVID-19 effects on the kidney].
Pathologe.
2021;
42(2):183-187.
Seeber C,
Popp M,
Meerpohl JJ,
et al .
COVID-19-Pandemie: Präferenzen und Barrieren für die Disseminierung von Evidenzsynthesen.
Anaesthesist.
2021;
[DOI]
Polotzek K,
Karch A,
Karschau J,
Wagner M,
Lünsmann B,
Menk M,
Römmele C,
Schmitt J.
COVID-19-Pandemie: Regionale Steuerung der Patienten.
Dtsch Arztebl International.
2021;
118(3):84—.
Ackermann M,
Werlein C,
Länger F,
Kühnel MP,
Jonigk DD.
COVID-19: Auswirkungen auf Lunge und Herz [COVID-19: effects on the lungs and heart].
Pathologe.
2021;
42(2):164-171.
Loyal L,
Braun J,
Henze L,
Kruse B,
Dingeldey M,
Reimer ea.
Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Science.
2021;
Loyal L,
et al .
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Science (New York, N.Y.).
2021;
[DOI]
Metzendorf M.
Das Cochrane COVID-19 Studienregister – eine studienbasierte, strukturierte Datenbank zur effizienten Identifizierung wissenschaftlicher Evidenz.
GMS Med Bibl Inf.
2021 Sep.;
21(1-2):Doc09.
[DOI]
Edler C,
Klein A,
Schröder A,
Sperhake J,
Ondruschka B.
Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®).
Leg Med (Tokyo).
2021 Jul.;
51101895.
[DOI]
Trimpert J,
et al .
Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines-A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters.
Viruses.
2021;
13
[DOI]
Schwabenland M,
Salié H,
Tanevski J,
Killmer S,
Lago M,
Schlaak A,
Mayer L,
Matschke J,
Püschel K,
Fitzek A,
Ondruschka B,
Mei H,
Boettler T,
Neumann-Haefelin C,
Hofmann M,
Breithaupt A,
Genc N,
Stadelmann C,
Saez-Rodriguez J,
Bronsert P,
Knobeloch K,
Blank T,
Thimme R,
Glatzel M,
Prinz M,
Bengsch B.
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions.
Immunity.
2021;
54(7):1594-1610.e11.
[DOI]
Schwarz T,
et al .
Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany.
Emerging infectious diseases.
2021;
27
[DOI]
Hoff N-,
et al .
Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction.
European Journal of Medical Research.
2021;
2698.
[DOI]
Arora P,
et al .
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance.
Cellular & Molecular Immunology.
2021;
182557—2559.
[DOI]
Baumann M,
Berghäuser M,
Bolz T,
Martens T.
Den Fokus neu denken - Skizze eines Pandemiemanagements auf Grundlage der Bedürfnisse und Lern- und Entwicklungserfordernissen von Kindern, Jugendlichen und Familien.
2021;
Holz J.
Der Erfolg Vietnams im Kampf gegen das Virus.
Südostasien. Zeitschrift für Politik, Kultur, Dialog.
2021 Feb.;
Casagrande M,
Fitzek A,
Spitzer M,
Püschel K,
Glatzel M,
Krasemann S,
Aepfelbacher M,
Nörz D,
Lütgehetmann M,
Pfefferle S,
Schultheiss M.
Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19.
Br J Ophthalmol.
2021;
105(8):1057-1061.
Döpfner M,
Adam J,
Habbel C,
et al .
Die psychische Belastung von Kindern und Jugendlichen und ihren Familien während der COVID-19-Pandemie und der Zusammenhang mit emotionalen und Verhaltensauffälligkeiten.
Bundesgesundheitsbl.
2021;
64
[DOI]
Döpfner M,
Adam J,
Habbel C,
Schulte B,
Schulze-Husmann K,
Simons M,
Heuer F,
Wegner C,
Bender S,
Herpertz-Dahlmann B,
others .
Die psychische Belastung von Kindern, Jugendlichen und ihren Familien während der COVID-19-Pandemie und der Zusammenhang mit emotionalen und Verhaltensauffälligkeiten.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
2021;
64(12):1522—1532.
[DOI]
Ahrens KF,
Neumann RJ,
Kollmann B,
Plichta MM,
Lieb K,
Tüscher O,
Reif A.
Differential impact of COVID-related lockdown on mental health in Germany.
World Psychiatry.
2021;
20(1):140—141.
[DOI]
Vanshylla K,
et al .
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.
Cell host & microbe.
2021;
[DOI]
Schlickeiser S,
Schwarz T,
Steiner S,
Wittke K,
Al Besher N,
Meyer O,
Kalus U,
Pruß A,
Kurth F,
Zoller T,
others .
Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses.
Front Immunol.
2021;
11628971.
[DOI]
Heinrich F,
Romich C,
Zimmermann T,
Kniep I,
Fitzek A,
Steurer S,
Glatzel M,
Nörz D,
Günther T,
Czech-Sioli M,
Fischer N,
Grundhoff A,
Lütgehetmann M,
Ondruschka B.
Dying of VOC-202012/01 - multimodal investigations in a death case of the SARS-CoV-2 variant.
Int J Legal Med.
2021;
1-10.
[DOI]
Deinhardt-Emmer S,
Wittschieber D,
Sanft J,
Kleemann S,
Elschner S,
Haupt ea.
Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage.
Elife.
2021;
10
Gieselmann L,
et al .
Effective high-throughput isolation of fully human antibodies targeting infectious pathogens.
Nature Protocols.
2021;
[DOI]
Deckert A,
Anders S,
Allegri M,
others .
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Trials.
2021;
22(1):
[DOI]
[Datei]
Deckert A,
Anders S,
Allegri M,
et al .
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Trials.
2021;
22(1):
[DOI]
Deckert A,
Anders S,
Allegri M,
others .
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling.
Trials.
2021;
22(1):
[DOI]
[Datei]
Deckert A,
Anders S,
De Allegri M,
et al .
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling.
Trials.
2021;
22(1):
[DOI]
Beschoner P,
Jarczok M,
Kempf M,
Weimer K,
Geiser F,
Hiebel N,
Erim Y,
Morawa E,
Steudte-Schmiedgen S,
Albus C,
Jerg-Bretzke L.
egePan-VOICE study on the psychosocial burden of the Covid-19 pandemic among medical technical assistants.
Z Psychosom Med Psychother.
2021;
Zellmer S,
Kahn M,
Ebigbo A,
et al .
Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland.
Z Gastroenterol.
2021;
59(8):
[DOI]
Kahn M,
Zellmer S,
Ebigbo A,
et al .
Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland.
Z Gastroenterol.
2021;
59(12):
[DOI]
Jensen B,
Luebke N,
Feldt T,
et al .
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.
Lancet Reg Health Eur.
2021;
8
[DOI]
Jensen B,
Luebke N,
Feldt T,
Keitel V,
Brandenburger T,
Kindgen-Milles D,
Lutterbeck M,
Freise NF,
Schoeler D,
Haas R,
Dilthey A,
Adams O,
Walker A,
Timm J,
Luedde T.
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany.
The Lancet regional health. Europe.
2021;
8100164.
[DOI]
Ruhl L,
et al .
Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
Signal transduction and targeted therapy.
2021;
6418.
[DOI]
Stillfried S,
Boor P,
PANDEMIcs D.
Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin.
Pathologe.
2021;
1-5.
[DOI]